Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Pipeline
By Phase
4 drugs in development
By Therapeutic Area
top 4
R&D Momentum
48/100
Pipeline Velocity
15/100
Trial Completion Rate
90/100
Pipeline Concentration
22/100
Pipeline Freshness
77/100
Strategic Signals
Activity
Last 14 days
Correction of Myopia Evaluation Trial 2 (COMET2): A Randomized Trial of the Effect of Progressive Addition Lenses Versus Single Vision Lenses on Low Myopia Associated With Large Accommodative Lags and Near Esophoria in Children
A Randomized Clinical Trial of Overminus Spectacle Therapy for Intermittent Exotropia
Low-Dose Atropine for Treatment of Myopia (Myopia Treatment Study)
Binocular Dig Rush Game Treatment for Amblyopia
A Randomized Trial of Bilateral Lateral Rectus Recession Versus Unilateral Lateral Rectus Recession With Medial Rectus Resection for Intermittent Exotropia
CGM Intervention in Teens and Young Adults With T1D (CITY): A Randomized Clinical Trial to Assess the Efficacy and Safety of Continuous Glucose Monitoring in Young Adults 14-<25 With Type 1 Diabetes
Home OCT-Guided Treatment Versus Treat and Extend for the Management of Neovascular AMD
Randomized Trial of Full-Time Occlusion Therapy for Intermittent Exotropia in Children
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Pipeline
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)